Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: Inhibition of amyloidogenesis

被引：0
|
作者：
Merlini, G.
Ascari, E.
Amboldi, N.
Bellotti, V.
机构：
来源：
Physical Review B: Condensed Matter | / 51卷 / 24期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PHASE-II STUDIES OF 4'-IODO-4'-DEOXYDOXORUBICIN IN ADVANCED NONSMALL CELL LUNG, COLON AND BREAST CANCERS
    SESSA, C
    CALABRESI, F
    CAVALLI, F
    CERNY, T
    LIATI, P
    SKOVSGAARD, T
    SORIO, R
    KAYE, SB
    ANNALS OF ONCOLOGY, 1991, 2 (10) : 727 - 731
  • [22] INVITRO ACTIVITY OF 4'-IODO-4'-DEOXYDOXORUBICIN ON HUMAN COLORECTAL-CANCER AS MEASURED BY A SHORT-TERM ANTIMETABOLIC ASSAY
    VILLA, R
    ZAFFARONI, N
    GIULIANI, F
    COLELLA, G
    SANFILIPPO, O
    SILVESTRINI, R
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 143 - 144
  • [23] MULTICENTER VS SINGLE CENTER PHASE-II EVALUATION OF 4'-IODO-4'-DEOXYDOXORUBICIN IN ADVANCED BREAST-CANCER
    SCHWARTSMANN, G
    PINEDO, HM
    ANNALS OF ONCOLOGY, 1991, 2 (10) : 703 - 706
  • [24] PHASE-II STUDY OF 4'-IODO-4'-DEOXYDOXORUBICIN IN PATIENTS WITH ADVANCED, MEASURABLE NONSMALL CELL LUNG-CANCER
    EBERHARDT, W
    NIEDERLE, N
    WILKE, H
    WEIDMANN, B
    HENSS, H
    ENGELHARDT, R
    ZEIDLER, D
    COLAJORI, E
    KERPELFRONIUS, S
    SEEBER, S
    ONKOLOGIE, 1993, 16 (06): : 446 - 448
  • [25] PHASE-II STUDY OF 4'-IODO-4'-DEOXYDOXORUBICIN IN NONRESECTABLE NON-SMALL-CELL LUNG-CANCER
    SORENSEN, JB
    STENBYGAARD, L
    DRIVSHOLM, L
    DOMBERNOWSKY, P
    HANSEN, HH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (05) : 399 - 402
  • [26] PHARMACOLOGY AND CLINICAL TOXICITY OF 4'-IODO-4'-DEOXYDOXORUBICIN - AN EXAMPLE OF SUCCESSFUL APPLICATION OF PHARMACOKINETICS TO DOSE ESCALATION IN PHASE-I TRIALS
    GIANNI, L
    VIGANO, L
    SURBONE, A
    BALLINARI, D
    CASALI, P
    TARELLA, C
    COLLINS, JM
    BONADONNA, G
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (06) : 469 - 477
  • [27] ABSOLUTE AND RELATIVE ACTIVITIES OF 4'-IODO-4'-DEOXYDOXORUBICIN AGAINST HUMAN COLORECTAL TUMORS, AS EVALUATED BY A SHORT-TERM INVITRO ASSAY
    VILLA, R
    ZAFFARONI, N
    GIULIANI, FC
    COLELLA, G
    SANFILIPPO, O
    SILVESTRINI, R
    ANTICANCER RESEARCH, 1990, 10 (01) : 105 - 108
  • [28] Intracellular distributions of the anthracycline 4′-iodo-4′-deoxy-doxorubicin and essential trace metals using nuclear microprobe analysis
    Ortega, R
    POLYCYCLIC AROMATIC COMPOUNDS, 2000, 21 (1-4) : 99 - 108
  • [29] PHARMACOKINETICS AND METABOLISM OF 4'-IODO-4'-DEOXY-DOXORUBICIN IN HUMANS
    ROBERT, J
    ARMAND, JP
    HUET, S
    KLINKALAKL, M
    RECONDO, G
    HURTELOUP, P
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1183 - 1190
  • [30] CARDIOTOXICITY AND CYTOTOXICITY OF THE ANTHRACYCLINE ANALOG 4'-DEOXY-4'-IODO-DOXORUBICIN
    DANESI, R
    BERNARDINI, N
    AGEN, C
    COSTA, M
    MACCHIARINI, P
    DELLATORRE, P
    DELTACCA, M
    TOXICOLOGY, 1991, 70 (02) : 243 - 253
12345